| After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica | Ben Fidler | 07/21/16 | San Francisco |
| As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO | Ben Fidler | 11/14/14 | San Francisco |
| Affymax Cuts 230 Jobs, Mulls Bankruptcy, After Drug Withdrawal | Luke Timmerman | 03/18/13 | San Francisco |
| Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen | Luke Timmerman | 03/27/12 | San Francisco |
| Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly | Luke Timmerman | 01/25/12 | San Francisco |
| Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug | Luke Timmerman | 12/07/11 | San Francisco |
| Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug | Luke Timmerman | 12/05/11 | San Francisco |
| Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny | Luke Timmerman | 11/17/11 | San Francisco |
